Neutralizing antibodies as a potential secondary protective mechanism during chronic SHIV infection in CD8+ T-cell-depleted macaques

Verfasser / Beitragende:
[Robert A Rasmussen, Regina Hofmann-Lehmann, Pei-Lin Li, Josef Vlasak, Joern E Schmitz, Keith A Reimann, Marcelo J Kuroda, Norman L Letvin, David C Montefiori, Harold M McClure, Ruth M Ruprecht]
Ort, Verlag, Jahr:
2002
Enthalten in:
AIDS, 16(6):829-838
Format:
Artikel (online)
ID: 390148059
LEADER cad a22 4500
001 390148059
005 20181103044323.0
007 cr unu---uuuuu
008 161201e20020412xx s 000 0 eng
024 7 0 |a 10.5167/uzh-128336  |2 doi 
024 7 0 |a 10.1097/00002030-200204120-00002  |2 doi 
035 |a (ZORA)oai:www.zora.uzh.ch:128336 
084 |a 570  |2 ddc 
084 |a 630  |2 ddc 
091 |a 11919484  |b pmid 
245 0 0 |a Neutralizing antibodies as a potential secondary protective mechanism during chronic SHIV infection in CD8+ T-cell-depleted macaques  |h [Elektronische Daten]  |c [Robert A Rasmussen, Regina Hofmann-Lehmann, Pei-Lin Li, Josef Vlasak, Joern E Schmitz, Keith A Reimann, Marcelo J Kuroda, Norman L Letvin, David C Montefiori, Harold M McClure, Ruth M Ruprecht] 
506 |a closedAccess  |2 eu-repo 
520 3 |a OBJECTIVE: To directly examine the role of CD8+ T cells in controlling viremia and disease during chronic, low-level primate immunodeficiency virus infection in DNA prime/protein boost-vaccinated macaques. BACKGROUND: A cohort of macaques, vaccinated with either a DNA prime/HIV-1 gp160 boost regimen or with gp160 alone was previously protected partially from sequential challenges with non-pathogenic and pathogenic strains of chimeric simian/human immunodeficiency virus (SHIV). In this study, the effect of temporary ablation of CD8+ T cells in these animals was examined. METHODS: Animals were treated with an anti-CD8 antibody and CD8+ T-cell levels in peripheral blood, plasma viral loads, peripheral blood mononuclear cell-associated virus levels, neutralizing antibody (nAb) titers and simian immunodeficiency virus Gag-specific CD8+ T-cell numbers were followed. RESULTS: Plasma viremia rose sharply in direct synchrony with a rapid but transient drop in CD8+ T cells. However, although levels of cell-associated virus also rose concomitantly, peak levels were much lower than those in virus-challenged, naive animals. In addition, despite a rise of pathogenic SHIV89.6P RNA levels in three animals, CD4+ T-cell counts remained unchanged. In each of these animals, neutralizing antibody titers against the pathogenic SHIV89.6P strain were high. CONCLUSIONS: The results indicate that CD8+ T cells play a key role in suppressing viremia in a chronically infected host. In addition, the results suggest that in the absence of CD8+ T cells, nAb may act as an effective second line of defense by limiting both the spread of infectious virus to new target cells and CD4+ T-cell loss. 
690 7 |a Department of Farm Animals  |2 zora 
700 1 |a Rasmussen  |D Robert A.  |e joint author 
700 1 |a Hofmann-Lehmann  |D Regina  |e joint author 
700 1 |a Li  |D Pei-Lin  |e joint author 
700 1 |a Vlasak  |D Josef  |e joint author 
700 1 |a Schmitz  |D Joern E.  |e joint author 
700 1 |a Reimann  |D Keith A.  |e joint author 
700 1 |a Kuroda  |D Marcelo J.  |e joint author 
700 1 |a Letvin  |D Norman L.  |e joint author 
700 1 |a Montefiori  |D David C.  |e joint author 
700 1 |a McClure  |D Harold M.  |e joint author 
700 1 |a Ruprecht  |D Ruth M.  |e joint author 
773 0 |t AIDS  |g 16(6):829-838 
856 4 0 |u https://www.zora.uzh.ch/id/eprint/128336/1/Neutralizing_antibodies_as_a_potential_secondary.2.pdf  |q text/html  |z WWW-Backlink auf das Repository 
908 |D 1  |a Journal Article  |z PeerReviewed  |2 zora 
950 |B ZORA  |P 856  |E 40  |u https://www.zora.uzh.ch/id/eprint/128336/1/Neutralizing_antibodies_as_a_potential_secondary.2.pdf  |q text/html  |z WWW-Backlink auf das Repository 
950 |B ZORA  |P 700  |E 1-  |a Rasmussen  |D Robert A.  |e joint author 
950 |B ZORA  |P 700  |E 1-  |a Hofmann-Lehmann  |D Regina  |e joint author 
950 |B ZORA  |P 700  |E 1-  |a Li  |D Pei-Lin  |e joint author 
950 |B ZORA  |P 700  |E 1-  |a Vlasak  |D Josef  |e joint author 
950 |B ZORA  |P 700  |E 1-  |a Schmitz  |D Joern E.  |e joint author 
950 |B ZORA  |P 700  |E 1-  |a Reimann  |D Keith A.  |e joint author 
950 |B ZORA  |P 700  |E 1-  |a Kuroda  |D Marcelo J.  |e joint author 
950 |B ZORA  |P 700  |E 1-  |a Letvin  |D Norman L.  |e joint author 
950 |B ZORA  |P 700  |E 1-  |a Montefiori  |D David C.  |e joint author 
950 |B ZORA  |P 700  |E 1-  |a McClure  |D Harold M.  |e joint author 
950 |B ZORA  |P 700  |E 1-  |a Ruprecht  |D Ruth M.  |e joint author 
950 |B ZORA  |P 773  |E 0-  |t AIDS  |g 16(6):829-838 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B ZORA  |F ZORA  |b ZORA  |j Journal Article  |c closedAccess